Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1992-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.89.11.4879PMID 1594588PMCID PMC49191
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lysyl oxidase and rrg messenger RNA.

  1991cited by this paper
• Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras.

  1990cited by this paper
• Regulation of collagen gene expression by transformed human fibroblasts: decreased type I and type III collagen RNA transcription.

  1990cited by this paper
• Microinjection of recombinant p21rho induces rapid changes in cell morphology

  1990cited by this paper
• Permanent conversion of mouse and human cells transformed by activated ras or raf genes to apparently normal cells by treatment with the antibiotic azatyrosine

  1989cited by this paper
• Nucleotide sequence of human rho cDNA clone 12.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Establishment of a human pancreatic adenocarcinoma cell line (PSN-1) with amplifications of both c-myc and activated c-Ki-ras by a point mutation.

  1986cited by this paper
• Improvement of the dideoxy chain termination method of DNA sequencing by use of deoxy-7-deazaguanosine triphosphate in place of dGTP.

  1986cited by this paper
• Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes.

  1986cited by this paper
• Exon structure of the collagen‐binding domain of human fibronectin

  1986cited by this paper
• A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.

  1985cited by this paper
• Constitutive synthesis of interleukin-3 by leukaemia cell line WEHI-3B is due to retroviral insertion near the gene

  1985cited by this paper
• Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies.

  1985cited by this paper
• Mechanism of activation of the mouse c‐mos oncogene by the LTR of an intracisternal A‐particle gene.

  1984cited by this paper
• Molecular cloning and the total nucleotide sequence of the human c-Ha-ras-1 gene activated in a melanoma from a Japanese patient.

  1984cited by this paper
• Transposition of two different intracisternal A particle elements into an immunoglobulin kappa-chain gene

  1984cited by this paper
• Intracisternal A-particle genes as movable elements in the mouse genome.

  1983cited by this paper
• Activation of the c-mos oncogene in a mouse plasmacytoma by insertion of an endogenous intracisternal A-particle genome.

  1983cited by this paper
• A simple and very efficient method for generating cDNA libraries.

  1983cited by this paper
• Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes.

  1983cited by this paper
• Heterogeneity of malignant cells from a human colonic carcinoma.

  1981cited by this paper
• L-beta-(5-hydroxy-2-pyridyl)-alanine and L-beta-(3-hydroxyureido)-alanine from Streptomyces.

  1975cited by this paper

• Rapid testing of candidate oncogenes and tumour suppressor genes in signal transduction and neoplastic transformation.

  2021cites this paper
• Inhibition of angiogenesis in endothelial cells by Human Lysyl oxidase propeptide

  2018cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2014cites this paper
• Lysyl Oxidase Polymorphisms and Susceptibility to Osteosarcoma

  2012cites this paper
• Vitamins and Trace Elements

  2011cites this paper
• LOX (lysyl oxidase)

  2011cites this paper
• Lysyl oxidase regulates MMTV promoter: indirect evidence of histone H1 involvement.

  2011cites this paper
• Lysyl oxidase: a potential target for cancer therapy

  2011influential citation
• The Lysyl Oxidase Propeptide Interacts with the Receptor-Type Protein Tyrosine Phosphatase Kappa and Inhibits β-Catenin Transcriptional Activity in Lung Cancer Cells

  2011influential citation
• Bedeutung der extrazellulären Kollagenmodifikationen für die Osteoblastendifferenzierung und Entstehung von Knochengewebe

  2010cites this paper
• What we learn from transformation suppressor genes: lessons from RECK.

  2010cites this paper
• Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC)

  2010cites this paper
• Lysyl Oxidase Pro-peptide Inhibits Prostate Cancer Cell Growth by Mechanisms that Target FGF-2-Cell Binding and Signaling

  2009cites this paper
• Lysyl oxidase (LOX) mRNA expression and genes of the differentiated osteoblastic phenotype are upregulated in human osteosarcoma cells by suramin.

  2008cites this paper
• Downregulation of HER2 by RIG1 involves the PI3K/Akt pathway in ovarian cancer cells.

  2008cites this paper
• The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer.

  2007cites this paper
• LOXL 1 and LOXL 4 Are Epigenetically Silenced and Can Inhibit Ras / Extracellular Signal-Regulated Kinase Signaling Pathway in Human Bladder Cancer

  2007cites this paper
• Stem cell gene expression changes induced specifically by mutated K-ras.

  2007cites this paper
• LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer.

  2007cites this paper
• Cloning of genes expressed in cell quiescence: a new function of the ras-recision/lysyl oxidase gene.

  2007cites this paper
• Driven Breast Cancer − Propeptide Reverses the Invasive Phenotype of Her-2 / neu The Tumor Suppressor Activity of the Lysyl Oxidase

  2007cites this paper
• Lysyl oxidase: an oxidative enzyme and effector of cell function

  2006cites this paper
• beta-catenin signaling and regulation of cyclin D1 promoter in NRK-49F cells transformed by down-regulation of the tumor suppressor lysyl oxidase.

  2005cites this paper
• Selective cytotoxicity of azatyrosinamides against ras-transformed NIH 3T3 cells.

  2005cites this paper
• Drosophila Lysyl Oxidases Dmloxl-1 and Dmloxl-2 Are Differentially Expressed and the Active DmLOXL-1 Influences Gene Expression and Development*

  2005cites this paper
• Identification and characterization of the retinoic acid response elements in the human RIG1 gene promoter.

  2005cites this paper
• A molecular role for lysyl oxidase‐like 2 enzyme in Snail regulation and tumor progression

  2005cites this paper
• Functional analysis of the promoter and first intron of the human lysyl oxidase gene

  2004cites this paper
• Cancers Methylation and Loss of Heterozygosity in Human Gastric Is a Tumor Suppressor Gene Inactivated by Lysyl Oxidase

  2004cites this paper
• The Propeptide Domain of Lysyl Oxidase Induces Phenotypic Reversion of Ras-transformed Cells*

  2004cites this paper
• Lysyl Oxidase Is a Tumor Suppressor Gene Inactivated by Methylation and Loss of Heterozygosity in Human Gastric Cancers

  2004cites this paper
• The LOX and LOXL2 amine oxidases in colon and esophageal cancer

  2003cites this paper
• Molecular Cancer Gene Expression Profiling by Dna Microarray Analysis in Mouse Embryonic Fibroblasts Transformed by Ras V12 Mutated Protein and the E1a Oncogene

  2003cites this paper
• Altered adhesion features and signal transduction in NRK-49F cells transformed by down-regulation of lysyl oxidase.

  2003cites this paper
• RhoGTPases and their role in cancer.

  2003cites this paper
• Demonstration of in vitro interaction between tumor suppressor lysyl oxidase and histones H1 and H2: definition of the regions involved.

  2003cites this paper
• Post-translational incorporation of the antiproliferative agent azatyrosine into the C-terminus of alpha-tubulin.

  2003cites this paper
• Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.

  2003cites this paper
• Molecular Cancer Gene Expression Profiling by Dna Microarray Analysis in Mouse Embryonic Fibroblasts Transformed by Ras V12 Mutated Protein and the E1a Oncogene

  2003cites this paper
• Autocrine Growth Factor Regulation of Lysyl Oxidase Expression in Transformed Fibroblasts*

  2003cites this paper
• Lysyl Oxidase Inhibits Ras-Mediated Transformation by Preventing Activation of NF-κB

  2003influential citation
• A molecular role for lysyl oxidase in breast cancer invasion.

  2002cites this paper
• Down-regulation of Lysyl Oxidase-induced Tumorigenic Transformation in NRK-49F Cells Characterized by Constitutive Activation of Ras Proto-oncogene*

  2001cites this paper
• Cloning and characterization of a fourth human lysyl oxidase isoenzyme.

  2001cites this paper
• Lysyl oxidases: a novel multifunctional amine oxidase family.

  2001cites this paper
• Differential expression of intracisternal A-particle transcripts in immunogenic versus tumorigenic S49 murine lymphoma cells.

  2000cites this paper
• Lysyl Oxidase Activates the Transcription Activity of Human Collagene III Promoter

  2000cites this paper
• Azatyrosine: Mechanism of Action for Conversion of Transformed Phenotype to Normal

  1999cites this paper
• Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene

  1999cites this paper
• Gene Trapping Identifies Inhibitors of Oncogenic Transformation

  1998cites this paper
• Flat revertant inducers, styryl diphenylamine derivatives, inhibit growth and metastasis of murine tumor cells in vivo.

  1997cites this paper
• Growth-inhibitory Activity and Downregulation of the Class II Tumor-suppressor Gene H-rev107 in Tumor Cell Lines and Experimental Tumors

  1997cites this paper
• The human lysyl oxidase-like gene maps between STS markers D15S215 and GHLC.GCT7C09 on chromosome 15

  1997cites this paper
• Functional analysis of the lysyl oxidase promoter in myofibroblast‐like clones of 3T6 fibroblast

  1997cites this paper
• Localization and activity of lysyl oxidase within nuclei of fibrogenic cells.

  1997cites this paper
• Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation--sign of tumour cell revertance?

  1997cites this paper
• Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma.

  1997cites this paper
• Micro‐injection of recombinant lysyl oxidase blocks oncogenic p21‐Ha‐Ras and progesterone effects on Xenopus laevis oocyte maturation

  1997cites this paper
• Drug-induced reversion of progression phenotype is accompanied by reversion of AP-1 phenotype in JB6 cells

  1996cites this paper
• Ki-ras point mutations and proliferation activity in biliary tract carcinomas.

  1996cites this paper
• Azatyrosine inhibits the activation of c-Raf-1, c-Jun and AP1 but not the activation of Ras during signal transduction triggered by oncogenic c-ErbB-2.

  1996cites this paper
• Stimulation of the expression of rhoB contributes to the ability of azatyrosine to convert c-erbB-2-transformed cells to a normal morphology.

  1996cites this paper
• Sensitivity to the parvovirus minute virus of mice as a probe for azatyrosine-mediated phenotypic reversion of spontaneously transformed cells.

  1996cites this paper
• Mammals II: Downstream of RAS and Actin-Cytoskeleton

  1996cites this paper
• Azatyrosine is incorporated into proteins instead of tyrosine residues, with the resultant conversion of transformed cells to cells with a normal phenotype.

  1996cites this paper
• A novel styryl diphenylamine derivative reverts the transformed phenotype of human fibrosarcoma HT1080 cells.

  1995cites this paper
• Synthesis and cellular characterization of the detransformation agent, (-)-depudecin.

  1995cites this paper
• Partial restoration of pre‐transformation levels of lysyl oxidase and transin mRNAs in phenotypic ras revertants

  1995cites this paper
• Morphology of ras-transformed cells becomes apparently normal again with tyrosine kinase inhibitors without a decrease in the ras-GTP complex.

  1995cites this paper
• A New Gene with Sequence and Structural Similarity to the Gene Encoding Human Lysyl Oxidase (*)

  1995cites this paper
• Expression of a retinoic Acid-inducible mitochondrial nd5 gene is regulated by cell-density in bovine papillomavirus DNA-transformed mouse c127 cells but not in revertant cells.

  1994cites this paper
• Suppression of ras oncogene-mediated transformation.

  1994cites this paper
• Subtraction cloning of H-rev107, a gene specifically expressed in H-ras resistant fibroblasts.

  1994cites this paper
• Lysyl oxidase cDNA of myofibroblast from mouse fibrotic liver.

  1994cites this paper
• The c-erbB-2 protein in oncogenesis: molecular structure to molecular epidemiology.

  1994cites this paper
• Functional identification and molecular cloning of a rat gene mediating growth inhibition and programmed cell death in normal and transformed rat cell lines.

  1994cites this paper
• Gene ecology: Acis-acting gene-to-gene interaction due to the spatial arrangement of genes in chromosomes affects neighbouring transfected c-H-ras expression

  1994cites this paper
• Detection of increased amounts of the extracellular domain of the c‐erbB‐2 oncoprotein in serum during pulmonary carcinogenesis in humans

  1994cites this paper
• Retinoic acid prevents downregulation of ras recision gene/lysyl oxidase early in adipocyte differentiation.

  1994cites this paper
• Suppression of ras-mediated transformation. Differential expression of genes encoding extracellular matrix proteins in normal, transformed and revertant cells.

  1993cites this paper
• Mechanisms of reversion

  1993cites this paper
• Pathways of Ras function: connections to the actin cytoskeleton.

  1993cites this paper
• Up-regulation of lysyl oxidase in spontaneous revertants of H-ras-transformed rat fibroblasts.

  1993cites this paper
• Role of GTPases and GTPase regulatory proteins in oncogenesis.

  1993cites this paper
• Inhibition of chemical carcinogenesis in vivo by azatyrosine.

  1992cites this paper
• Azatyrosine inhibits neurite outgrowth of PC12 cells induced by oncogenic Ras.

  1992cites this paper
• New nucleotide sequence data on the EMBL File Server.

  1992cites this paper